Cipla is currently trading at Rs. 1178.10, up by 27.95 points or 2.43% from its previous closing of Rs. 1150.15 on the BSE. The scrip opened at Rs. 1155.55 and has touched a high and low of Rs. 1196.85 and Rs. 1151.00 respectively. So far 45211 shares were traded on the counter. The BSE group … Read more
Cipla is currently trading at Rs. 911.15, up by 7.05 points or 0.78% from its previous closing of Rs. 904.10 on the BSE. The scrip opened at Rs. 904.00 and has touched a high and low of Rs. 923.55 and Rs. 887.65 respectively. So far 91680 shares were traded on the counter. The BSE group … Read more
Cipla is currently trading at Rs. 932.10, up by 2.65 points or 0.29% from its previous closing of Rs. 929.45 on the BSE. The scrip opened at Rs. 933.95 and has touched a high and low of Rs. 936.15 and Rs. 923.40 respectively. So far 50972 shares were traded on the counter. The BSE group … Read more
Cipla’s wholly owned subsidiary — Goldencross Pharma has completed the closing of Wellthy Therapeutics, transaction representing an acquisition of 11.71% stake in Wellthy on fully diluted basis on March 08, 2019. Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio … Read more
